✦ LIBER ✦

GM-CSF as adjuvant for immunotherapy with bispecific antibodies

✍ Scribed by D Elsässer; H Stadick; J.G.J van de Winkel; T Valerius

Book ID: 117666749
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 104 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)00086-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative studies of Avipox-GM-CSF ver

Comparative studies of Avipox-GM-CSF versus recombinant GM-CSF protein as immune adjuvants with different vaccine platforms

✍ E. Reali; D. Canter; H. Zeytin; J. Schlom; J.W. Greiner 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 619 KB

Use of GM-CSF as an adjuvant with cancer

Use of GM-CSF as an adjuvant with cancer vaccines: beneficial or detrimental?

✍ Clive, Kevin S; Tyler, Josh A; Clifton, G Travis; Holmes, Jarrod P; Mittendorf, 📂 Article 📅 2010 🏛 Expert Reviews 🌐 English ⚖ 320 KB

Immunotherapy with the bispecific antibo

Immunotherapy with the bispecific antibody MDX-H210 (anti-HER2 × anti-CD64) combined with GM-CSF in HER2 positive hormone resistant prostatic cancer

✍ James, N.D.; Atherton, P.J.; Howie, A.J.; Tchekmedyian, S.; Curnow, R.T. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Tumor-associated glycoantigen, sialyl Le

Tumor-associated glycoantigen, sialyl Lewisa as a target for bispecific antibody-directed adoptive tumor immunotherapy

✍ So Ohta; Hideo Tsukamoto; Kazuhito Watanabe; Koji Makino; Soichi Kuge; Nobuo Han 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 507 KB

Anti-GD2 Antibody with GM-CSF, Interleuk

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

✍ Yu, Alice L.; Gilman, Andrew L.; Ozkaynak, M. Fevzi; London, Wendy B.; Kreissman 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 357 KB

Human C-ERBB-2 proto-oncogene product as

Human C-ERBB-2 proto-oncogene product as a target for bispecific-antibody-directed adoptive tumor immunotherapy

✍ Takashi Nishimura; Yoshihiko Nakamura; Hideo Tsukamoto; Yasuhiro Takeuchi; Yutak 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 559 KB

To develop an efficient strategy for the targeting of antitumor effector cells, we prepared bispecific antibody (BsAb) containing anti-CD3 and an anti-c-erbB-2 proto-oncogene product. The prepared BsAb specifically reacts with both c-erb6-2positive tumor cells and CD3+ CTL. Human CD4' helper/killer